Get the Stockscreener App
1.93
3.76%
0.07
After Hours:
1.96
0.03
+1.55%
Omniab Inc stock is traded at $1.93, with a volume of 234.38K.
It is up +3.76% in the last 24 hours and up +40.88% over the past month.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
See More
Previous Close:
$1.86
Open:
$1.87
24h Volume:
234.38K
Relative Volume:
0.22
Market Cap:
$188.40M
Revenue:
$34.16M
Net Income/Loss:
$-50.62M
P/E Ratio:
-3.7992
EPS:
-0.508
Net Cash Flow:
$703.00K
1W Performance:
+14.20%
1M Performance:
+40.88%
6M Performance:
-47.55%
1Y Performance:
-47.12%
1-Day Range:
$1.81
$1.93
1-Week Range:
$1.655
$1.93
52-Week Range:
$1.22
$4.96
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.93 | 188.40M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OmniAb Elects Directors at Annual Shareholder Meeting - TipRanks
OmniAb shareholders elect two directors at annual meeting - Investing.com
OmniAb Inc Inc. (OABI) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Squarepoint Ops LLC - Defense World
Millennium Management LLC Buys 61,993 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
June 2025's Promising Penny Stocks to Consider - Yahoo Finance
OmniAb, Inc. (NASDAQ:OABI) Stake Cut by Jane Street Group LLC - Defense World
AI Is Rewiring Healthcare Faster Than Expected — Investors Are Hunting for Public Winners Now - The Globe and Mail
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.025 per Common Limited Partner Unit - The Globe and Mail
OmniAb, Inc. (NASDAQ:OABI) Shares Purchased by ProShare Advisors LLC - Defense World
BNP Paribas Financial Markets Buys Shares of 17,549 OmniAb, Inc. (NASDAQ:OABI) - Defense World
Bank of America Corp DE Has $2.18 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OABI stock touches 52-week low at $1.25 amid market challenges - Investing.com Australia
OABI stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Northern Trust Corp Acquires 45,169 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deutsche Bank AG Increases Stake in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass - insights.citeline.com
OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada
OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister
Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st
Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance
51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World
Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World
Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus
Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks
Insider Buying: Steven Love Acquires 25,000 Shares of OmniAb Inc (OABI) - GuruFocus
Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks
Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com
Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World
OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha
OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN
OmniAb : May 2025 Corporate Overview - marketscreener.com
Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st
Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail
OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb Introduces the xPloration® Partner Access Program - BioSpace
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa
Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com
OmniAb Reports Steady Growth in Q1 2025 - TipRanks
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omniab Inc Stock (OABI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Love Steven | Director |
May 14 '25 |
Buy |
1.46 |
25,000 |
36,500 |
38,333 |
| HIGGINS JOHN L | Director |
May 12 '25 |
Buy |
1.44 |
65,000 |
93,600 |
2,831,887 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '25 |
Option Exercise |
0.00 |
36,458 |
0 |
3,815,618 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '25 |
Sale |
2.00 |
19,382 |
38,764 |
3,796,236 |
| Berkman Charles S | Chief Legal Officer |
Apr 07 '25 |
Option Exercise |
0.00 |
13,542 |
0 |
370,418 |
| Berkman Charles S | Chief Legal Officer |
Apr 07 '25 |
Sale |
2.00 |
7,206 |
14,412 |
363,212 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Apr 07 '25 |
Option Exercise |
0.00 |
13,542 |
0 |
231,034 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Apr 07 '25 |
Sale |
2.00 |
7,206 |
14,412 |
223,828 |
0.68%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):